PTC Therapeutics, Inc. (PTCT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 6.04B |
| Enterprise Value | 5.55B |
| P/E Ratio | -34.69 |
| PEG Ratio | 0.27 |
| Price/Sales Ratio | 8.12 |
| Price/Book Ratio | -37.02 |
| Enterprise/Revenue | 7.59 |
| Enterprise/EBITDA | -52.5 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.23 |
| Operating Margin | -0.08 |
| Return On Assets | -0.07 |
| Return On Equity | 1 |
| Revenue | 1.73B |
| Revenue/Share | 10.02 |
| Gross Profit | 1.66B |
| EBITDA | 887.66M |
| Net Income | 682.64M |
| Diluted EPS | 7.78 |
| Total Cash | 1.89B |
| Total Cash/Share | 22.93 |
| Total Debt | 395.09M |
| Total Debt/Equity | -2.19 |
| Current Ratio | 2.44 |
| Book Value Per Share | -2.19 |
| 52-Week Change | 63.23 |
| 52-Week High | 87.5 |
| 52-Week Low | 43.18 |
| Moving Average 50 Days | 71.23 |
| Moving Average 200 Days | 70.41 |
| Average Volume | 1.41M |
| Shares Outstanding | 82.95M |
| % Held by Institutions | 118.35 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |